Anacor Pharmaceuticals
Anacor was a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. It was acquired by Pfizer in 2016 for approximately $5.2 billion.
7-day free trial · no credit card
Verified contacts
28
available on Kipplo
LinkedIn employees
34
51 to 200 range
Open roles
—
no listings
Distinct roles
26
indexed titles
Tech stack
2
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 28 verified contacts at Anacor Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
28 contacts with verified email or phone · masked until revealed.
- YF
Yvonne Freund
Director Pharmacology · Research & Development
EmailPhone - DL
Diane Larrea
Mgr, Financial Planning and Analysis · Other
EmailPhone - SK
Sharon Kokubun
Accounting Finance · Finance & Accounting
EmailPhone - CR
Carmen R. Rodriguez
Ó É · Other
EmailPhone - IH
Irwin Heyman
Vice President Toxicology · Other
EmailPhone - KM
Kevin Munoz
CEO · General Business & Management
EmailPhone
Showing 6 of 28 verified contacts
Top roles at Anacor Pharmaceuticals
26 distinct titles indexed · top 10 shown.
- 1accounting finance
- 1ana paula 52hotmail com
- 1associate director, cmc
- 1atolye
- 1ceo
- 1compound management associate
- 1directeur des ressources humainnes
- 1director pharmacology
- 1exec asst
- 1executive administrator
- +16more titles
Sign up to unlock all 28 contacts at Anacor Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 28 verified contacts at Anacor Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.